List of Studies ( Metabolite:Hex2Cer 34:1;O2)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004217 | AN007016 | Lipid Alterations in ASAH1-Deficient Cells: Insights into Ceramide Accumulation and Lysosomal Dysfunction | Cultured cells | Human | Metabolic disease | Harvard Medical School | LC-MS |
| ST004138 | AN006861 | Variation in microbiome and metabolites are associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus | Feces | Human | Autoimmune disease | Hangzhou Xixi Hospital | LC-MS |
| ST004138 | AN006861 | Variation in microbiome and metabolites are associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus | Feces | Human | Liver disease | Hangzhou Xixi Hospital | LC-MS |
| ST004002 | AN006601 | A deep, quantitative lipid atlas of extracellular vesicles across multiple cell lines | Extracellular vescicles | Human | Cancer | European Molecular Biology Laboratory | LC-MS |
| ST004002 | AN006601 | A deep, quantitative lipid atlas of extracellular vesicles across multiple cell lines | Extracellular vescicles | Mouse | Cancer | European Molecular Biology Laboratory | LC-MS |
| ST003785 | AN006219 | Sex differences in lipid profiles of visceral adipose tissue with obesity and gonadectomy | Tissue | Mouse | Obesity | University of Michigan | LC-MS |
| ST003051 | AN005002 | Shotgun lipidomics of breast cancer endocrine therapy persisters | Breast cancer cells | Human | Cancer | Dartmouth College | LC-MS |
| ST003051 | AN005003 | Shotgun lipidomics of breast cancer endocrine therapy persisters | Breast cancer cells | Human | Cancer | Dartmouth College | LC-MS |
| ST003044 | AN004993 | A High-Fat Eucaloric Diet Induces Reprometabolic Syndrome of Obesity in Normal Weight Women - lipidomics | Blood | Human | Obesity | University of Colorado Denver | LC-MS |
| ST003040 | AN004989 | MM.1S Myeloma tumor cells and tumors made by subcutaneously injecting 1M Luc+/GFP+ MM.1S cells treated with 50 μM BMS309403 and Vehicle (PBS with a matched concentration of 5% DMSO) | Cultured cells | Human | Cancer | MaineHealth Institute for Research | LC-MS |
| ST002713 | AN004397 | Ranolazine induced metabolic rewiring improves melanoma responses to targeted therapy and immunotherapy - lipidomics | Cultured cells | Human | Cancer | University of Colorado Denver | LC-MS |
| ST002522 | AN004156 | Lipidomics study on the effect of LBP protein on hepatic lipid composition in mice | Liver | Mouse | Oxidative stress | University of Science and Technology of China | LC-MS |
| ST002438 | AN003973 | Ozone alters glycosphingolipid metabolism and exacerbates characteristics of asthma in mice | Lung | Mouse | Asthma | University of California, Davis | LC-MS |
| ST002411 | AN003930 | Spatial, temporal, and inter-subject variation of the metabolome along the human upper intestinal tract (MS RP negative data) | Intestine | Human | University of California, Davis | LC-MS | |
| ST001637 | AN002677 | A Metabolome Atlas of the Aging Mouse Brain | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST000991 | AN001617 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IX) | Blood | Human | University of California, Davis | LC-MS | |
| ST000990 | AN001616 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VIII) | Blood | Human | University of California, Davis | LC-MS | |
| ST000989 | AN001615 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VII) | Blood | Human | University of California, Davis | LC-MS | |
| ST000988 | AN001614 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VI) | Blood | Human | University of California, Davis | LC-MS | |
| ST000987 | AN001613 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part V) | Blood | Human | University of California, Davis | LC-MS | |
| ST000986 | AN001612 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IV) | Blood | Human | University of California, Davis | LC-MS | |
| ST000984 | AN001610 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part II) | Blood | Human | University of California, Davis | LC-MS | |
| ST000983 | AN001609 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (Part I) | Blood | Human | University of California, Davis | LC-MS |
